Opioid Use in the Elderly a Dementia Risk Factor?
The impact of opioid exposure on dementia risk in those aged 75-80 years is similar to that of other potentially modifiable risk factors for dementia.
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The impact of opioid exposure on dementia risk in those aged 75-80 years is similar to that of other potentially modifiable risk factors for dementia.
Greater percentages of patients treated with one of two doses of the novel IL-17 blocker achieved an ACR 50 response vs placebo.
Short-term methotrexate used in patients with arthralgia sustainably reduced disease burden and inflammation on MRI in all at-risk groups, according to the first data on pre-RA disease modification.
A cross-sectional study of patient-reported outcomes showed that female reports of quality of life plateaued while males continued to improve.
Recommendations for the management of patients with axial spondyloarthritis (axSpA) emphasize both pharmacologic and nonpharmacologic therapies.